Frutarom Expands Its Natural Ingredients Activity and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Frutarom Expands Its Natural Ingredients Activity and Enhances Its Capabilities in Algae-Based Biotech Products

HERZLIYA, Israel, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Frutarom Industries Ltd. (" Frutarom "), one of the world's 10 largest flavors and specialty natural ingredients companies, continues implementation of  its rapid and profitable growth strategy with emphasis on specialty natural ingredients for the food, nutritional supplements, pharmaceutical and cosmetics industries, today announces  the signing of an agreement to  invest in Algalo Industries Ltd. (" Algalo "). Frutarom will invest a total of NIS 10 million (approx. US$ 2.6 million) in exchange for the allocation of 50% of Algalo shares  to build  a modern biotechnology facility that will specialize in cultivation, harvesting and processing algae using advanced methods. Frutarom will have exclusive worldwide marketing rights for Algalo products.

Algalo, a promising biotech startup enterprise, has developed a unique and innovative method for the efficient cultivation, harvesting and processing of a wide variety of algae that yield active ingredients for use in the food, dietary and clinical nutrition supplements and cosmetics industries including strong antioxidants, lipids and unique proteins and carotenoids which help in maintaining cardio-vascular health, a strong immune system, and healthy skeletal and bone structure.

The unique technology developed by Algalo allows for the efficient and competitive cultivation of algae containing high concentrations of active elements.

Algalo's activity will join Frutarom's well-established activity in the field of algae cultivation and production of active ingredients (polysaccharides) currently being used by some the world's leading cosmetics companies for use in their skin care and protection products.

Ori Yehudai, President and CEO of Frutarom Group , said: "The investment in Algalo is part of a broad strategic move by Frutarom to reinforce its position and standing as a leading and innovative global supplier of natural specialty products and functional food ingredients in the fields of taste and health which already now make up over 75% of Frutarom's activity. The technology developed by Algalo for cultivating, harvesting and processing algae expands Frutarom's internal research and development capabilities for producing active ingredients from algae, a field in which we are already active, and provides an innovative platform and an additional growth engine for expanding Frutarom's diverse product portfolio in the growing field of natural specialty ingredients. We will work towards leveraging the cross-selling opportunities arising from this investment by expanding Frutarom's product portfolio and technological abilities and by presenting Algalo's innovative products to our thousands of customers worldwide.

"The size of the algae-based ingredient market is estimated to be hundreds of millions of dollars andhas enjoyed double-digit growth over recent years .We foresee the rapid growth in this market continuing in coming years in light of consumer trends towards healthier and more natural products that drive the food, nutritional supplements and cosmetics companies to be innovative in developing natural ingredients and efficient in their production processes and cost structure," continued Mr. Yehudai .

"Frutarom believes that biotechnology represents the next generation in the development and production of innovative natural ingredients for the industries which it serves, and the Company intends to continue expanding its capabilities in this area by intensifying investment in R&D within its laboratories as well as through additional investments and joint ventures with research institutions, universities and startup companies to which Frutarom can contribute from its experience in applied R&D, its industrial manufacturing and from its global deployment in over 150 countries with sales to more than 20,000 customers including leading global companies in foods and beverages, nutritional supplements, pharmaceuticals and cosmetics," concluded Mr. Yehudai .

About Frutarom:

Frutarom (LSE: FRUT ), (TASE: FRUT ) is a leading global company operating in the global flavors and natural fine ingredients markets. Frutarom has significant production and development centers on all six continents and markets and sells over 43,000 products to more than 20,000 customers in over 150 countries. Frutarom’s products are intended mainly for the food and beverages, flavor and fragrance extracts, pharmaceutical, nutraceutical, health food, functional food, food additives and cosmetics industries.

Frutarom, which employs more than 4,000 people worldwide, has 2 main core activities:

  • The Flavors Activity which develops, produces and markets flavor compounds and food systems;
  • The Specialty Fine Ingredients Activity, which develops, produces and markets natural flavor extracts, natural functional food ingredients, natural pharma/nutraceutical extracts, natural algae-based biotechnical products, natural food colors, natural substances for food protection, aroma compounds, essential oils, unique citrus products, natural gums and resins. The Specialty Fine Ingredients products are sold primarily to the food and beverages, flavor and fragrance, pharmaceutical/nutraceutical, cosmetics and personal care industries.

Frutarom’s products are produced at its plants in the US, Canada, the UK, Switzerland, Germany, Belgium, Italy, Spain, Slovenia, Russia, Turkey, Israel, South Africa, China, India, Guatemala, Peru, Chile, Brazil and New Zealand. The Company’s global marketing organization encompasses branches in Israel, the US, Canada, the UK, Switzerland, Germany, Austria, Slovenia, Belgium, the Netherlands, Denmark, France, Italy, Spain, Hungary, Romania, Russia, Ukraine, Poland, Kazakhstan, Belarus, Turkey, Brazil, Mexico, Guatemala, Costa Rica, Peru, Chile, South Africa, China, Japan, Hong Kong, India, Indonesia and New Zealand. The Company also works through local agents and distributors throughout the world. For further information, please visit our website at: www.frutarom.com .

CONTACT: Contact Details: ir@frutarom.com +972-9-9603800

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 956

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 251

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 295

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 307

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Consciousness at the CONTACT Modalities XPO Gathering

Updated Category News Views 271

CONTACT Modalities XPO: A Unique Gathering for Consciousness Exploration Prepare to embark on a transformative journey of self-discovery and exploration at the CONTACT Modalities XPO. This gathering promises to bring together passionate individuals eager to delve into consciousness studies through engaging sessions and workshops. The event will be held at the stunning...

Continue Reading
Green Thumb Industries Set to Unveil Q3 2025 Financial Overview

Updated Category News Views 266

Green Thumb Industries to Report Third Quarter Financial Results Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a standout in the cannabis consumer packaged goods sector, is poised to unveil its financial performance for the third quarter of 2025. The eagerly anticipated announcement will occur after market hours on November 5, 2025. Known for its growth and...

Continue Reading
Boussard & Gavaudan Holding: Estimated NAV Update

Updated Category News Views 129

About Boussard & Gavaudan Holding Limited Boussard & Gavaudan Holding Limited aims to keep shareholders informed—plain and simple. The company provides timely updates on its estimated net asset values (NAVs) and on the performance of its Euro and Sterling share classes, so you can track what matters without guesswork. How the Estimated NAV Is Determined Each month, the...

Continue Reading
Booming Yacht Rental Market Set to Surpass $13 Billion Milestone

Updated Category News Views 93

The yacht rental market hit a turning point, projected to exceed $13.1 billion in value—back when those forecasts came out, traders were buzzing about it. The allure of luxury travel had folks flocking to yacht rentals like moths to a flame. Market Drivers: Luxury Demand or Overhyped? High-net-worth individuals fueled the demand for yacht rentals, as they sought...

Continue Reading
Hellenic Telecom Completes Share Repurchase, Strengthening Value

Updated Category News Views 156

Hellenic Telecom's Successful Share Buyback Program Hellenic Telecommunications Organization S.A. (ATH:HTO), widely recognized as OTE, has recently finished a significant week of share repurchasing. In a strategic move, the company acquired a total of 414,128 shares, investing approximately €6.16 million at an average price of €14.87 per share. Understanding the Share...

Continue Reading